(Q37180867)

18 August 2017

1 reference

title

Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity? (English)

1 reference

medroxyprogesterone acetate

18 August 2017

1 reference

1 reference

1

R Kent Hermsmeyer

0 references

author name string

Theresa L Thompson

series ordinal

2

1 reference

18 August 2017

Gerald M Pohost

series ordinal

3

1 reference

18 August 2017

Juan Carlos Kaski

series ordinal

4

1 reference

18 August 2017

publication date

3 June 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

387-395

1 reference

Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

Ovarian conservation at the time of hysterectomy for benign disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

The rise and fall of menopausal hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Evidence-based guidelines for cardiovascular disease prevention in women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Estrogen therapy and coronary-artery calcification.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

All progestins are not created equal

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Assessment of the potency of orally administered progestins in women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Retinal vascular calibre and the risk of coronary heart disease-related death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Sleep apnea and hormone replacement therapy: a pilot study and a literature review.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Effects of progesterone on sleep: a possible pharmacological treatment for sleep-breathing disorders?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Effects of estrogen plus progestin on health-related quality of life

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Sleep and cardiac symptoms amongst women aged 40-64 years.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Preclinical evaluation of intrauterine progesterone as a contraceptive agent. III. Embryology and toxicology

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Mass spectrometric and high-performance liquid chromatographic studies of medroxyprogesterone acetate metabolites in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Hormone replacement therapy, inflammation, and hemostasis in elderly women

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Nomegestrol acetate and vascular reactivity: nonhuman primate experiments

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Twice-weekly transdermal estradiol and vaginal progesterone as continuous combined hormone replacement therapy in postmenopausal women: a 1-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1234

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1234

1 reference

18 August 2017

1 reference